Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2024-04-16 00:00:00 ET · period of report 2024-04-14 · accession 0001104659-24-047957 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-16 | 2024-04-14 | RYTM | Mazabraud Yann | EVP, Head of International | M - OptEx | — | -10.4K | 34.9K | -23% | — |
| DM | 2024-04-16 | 2024-04-15 | RYTM | Mazabraud Yann | EVP, Head of International | A - Grant | $0.00 | +18.9K | 8,905 | New | $0 |
| DM | 2024-04-16 | 2024-04-15 | RYTM | Mazabraud Yann | EVP, Head of International | D - Sale to Iss | $0.00 | -8,905 | 0 | -100% | $0 |
| D | 2024-04-16 | 2024-04-14 | RYTM | Mazabraud Yann | EVP, Head of International | M - OptEx | $0.00 | -10.4K | 31.1K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-14 | M | D | 10,375 | — | 34,870 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. |
| 2 | Derivative | Restricted Stock Units | 2024-04-15 | A | A | 10,000 | $0.00 | 10,000 | D | — · — to — | 10,000 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F8) The restricted stock units vest or have vested as to 25% of the total shares on each of April 15, 2025, April 15, 2026, April 15, 2027 and April 15, 2028. The restricted stock units have no expiration date. |
| 3 | Derivative | Restricted Stock Units | 2024-04-15 | D | D | 2,031 | $0.00 | 0 | D | — · — to — | 2,031 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F4) The restricted stock units vest or have vested as to 25% of the total shares on each of February 11, 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date. |
| 4 | Derivative | Restricted Stock Units | 2024-04-15 | D | D | 6,874 | $0.00 | 0 | D | — · — to — | 6,874 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F6) The restricted stock units vest or have vested as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date. |
| 5 | Derivative | Restricted Stock Units | 2024-04-15 | A | A | 8,905 | $0.00 | 8,905 | D | — · — to — | 8,905 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F7) The restricted stock units vest in full on April 15, 2025. The restricted stock units have no expiration date. |
| 6 | Derivative | Restricted Stock Units | 2024-04-14 | M | D | 10,375 | $0.00 | 31,125 | D | — · — to — | 10,375 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F2) The restricted stock units vest or have vested as to 25% of the total shares on each of April 14, 2024, April 14, 2025, April 14, 2026 and April 14, 2027. The restricted stock units have no expiration date. |